Production of IL-6 and Phagocytosis Are the Most Resilient Immune Functions in Metabolically Compromised Human Monocytes
Pierre-Louis Krauß(Humboldt-Universität zu Berlin), Frank Buttgereit(German Rheumatism Research Centre)
Cited by 10
Related Papers
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force
|Annals of the Rheumatic Diseases|2016|331
Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis
|Annals of the Rheumatic Diseases|2016|231
Barriers and potential solutions in the recruitment and retention of older patients in clinical trials—lessons learned from six large multicentre randomized controlled trials
|Age and Ageing|2021|48
The OMERACT Core Domain Set for Outcome Measures for Clinical Trials in Polymyalgia Rheumatica
|The Journal of Rheumatology|2017|46